Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Irritable Bowel Syndrome, January 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 96 articles: HTML format

Single Articles

1. LORSCH ZS, Liddle RA
   Mechanisms and clinical implications of gut-brain interactions.
   J Clin Invest. 2026;136:e196346.
   PubMed    
   Abstract available
   
   

2. ZHANG HM, Zhang Y, Luo GJ, Zhang AX, et al
   Human umbilical cord mesenchymal stem cells alleviated diarrhea-type irritable bowel syndrome by improving intestinal function.
   World J Stem Cells. 2025;17:112100.
   PubMed    
   Abstract available
   
   

3. SHANG S, Liu Y, Bai QL, Zhang Z, et al
   Latent myofascial trigger point injection improves symptoms in functional gastrointestinal disorders.
   World J Gastrointest Surg. 2025;17:111359.
   PubMed    
   Abstract available
   
   

4. VASSALOS CM, Koutelekos I, Vassalou E
   Assessment of Prevalence of Dientamoeba fragilis and Its Associated Factors Compared to Those of Giardia lamblia and Blastocystis sp. Among Greek Patients with Suspicion of Intestinal Parasitosis.
   Adv Exp Med Biol. 2026;1490:181-189.
   PubMed    
   Abstract available
   
   

5. WU W, Qiu Y, Liang F, Lu W, et al
   Acupuncture and moxibustion in irritable bowel syndrome: a mechanistic exploration from heart rate variability to cardiac metabolism.
   Front Neurol. 2025;16:1716708.
   PubMed    
   Abstract available
   
   

6. SZURA E, Poniewierka E
   Impact of physical activity and selected relaxation techniques on the quality of life of female patients with irritable bowel syndrome.
   Prz Gastroenterol. 2025;20:439-442.
   PubMed    
   Abstract available
   
   

7. SINGH A, Singh R
   The gastrointestinal endothelin system: receptors, cellular actions, and involvement in gastrointestinal disorders.
   Prz Gastroenterol. 2025;20:372-381.
   PubMed    
   Abstract available
   
   

8. BALLENA-CAICEDO J, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, Valladares-Garrido MJ, et al
   Prevalence of irritable bowel syndrome in medical students: a systematic review and meta-analysis.
   Front Med (Lausanne). 2025;12:1714085.
   PubMed    
   Abstract available
   
   

9. CHIU YT, Lee FJ, Kuo CY, Yang PC, et al
   The Post-Cholecystectomy Gut Microbiota Follows a Time-Varying Change-A Pilot Study.
   JGH Open. 2025;9:e70329.
   PubMed    
   Abstract available
   
   

10. LEPCZYNSKA M
    The interplay between Blastocystis and human gut microbiota.
    Ann Parasitol. 2025;71:171-184.
    PubMed    
    Abstract available
    
    

11. CHAVHAN PKB, Sayeed MS, Saiyad SS, Shah MN, et al
    Lactose Intolerance in Irritable Bowel Syndrome: Prevalence, Subtype Correlations, and Clinical Predictors in an Indian Cohort.
    Cureus. 2025;17:e97697.
    PubMed    
    Abstract available
    
    

12. PUSHADAPU VVSK, Srikar G
    Development and evaluation of chitosan-xanthan gum-based controlled release nanoparticles of mebeverine hydrochloride for targeted IBS therapy: in silico, in vitro, and in vivo investigations.
    Daru. 2025;34:6.
    PubMed    
    Abstract available
    
    

13. POPA IV, Dranga M, Nedelciuc O, Mihai C, et al
    Artificial Intelligence Methods for the Differential Diagnosis of Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Systematic Review.
    J Gastrointestin Liver Dis. 2025;34:510-514.
    PubMed    
    Abstract available
    
    

14. MOU JJ, Xu L, Luo YF, Tao QF, et al
    Assessing the Efficacy and Safety of Multiple Drugs for IBS-C: A Systematic Review and Network Meta-Analysis.
    J Gastrointestin Liver Dis. 2025;34:503-509.
    PubMed    
    Abstract available
    
    

15. DU Y, Xu H, Xiong J, Wang Z, et al
    Tracing Evolution of Hotspots and Frontiers: A Bibliometric Exploration of Acupuncture Therapy in Irritable Bowel Syndrome.
    J Multidiscip Healthc. 2025;18:8133-8152.
    PubMed    
    Abstract available
    
    

16. SAHU SK, Nath P, Mallick B, Praharaj D, et al
    Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review.
    Cureus. 2025;17:e97523.
    PubMed    
    Abstract available
    
    

17. GUAGNOZZI D, Gonzalez-Castro AM, Zabana Y, Fernandez-Banares F, et al
    Integrated Multi-Omic Analysis Identifies Altered Colonic Brush Border Profile as a Key Feature of Microscopic Colitis.
    United European Gastroenterol J. 2026;14:e70156.
    PubMed    
    Abstract available
    
    

18. MIDENFJORD I, Khadija M, Sundelin E, Trindade IA, et al
    Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project.
    United European Gastroenterol J. 2026;14:e70157.
    PubMed    
    Abstract available
    
    

19. CAI E, Kouznetsova VL, Tsigelny IF
    Metabolomics-Based Machine Learning Diagnostics of Post-Acute Sequelae of SARS-CoV-2 Infection.
    Metabolites. 2025;15:801.
    PubMed    
    Abstract available
    
    

20. AL-MADHAGI H
    A Systems Biology and Drug Repositioning Approach for the Analysis of Mutual Genes Between Celiac Disease and Irritable Bowel Syndrome.
    Biomed Res Int. 2025;2025:8227229.
    PubMed    
    Abstract available
    
    

21. SUN F, Li H, Gong B, Hui S, et al
    Investigating the Causal Relationship and Shared Genetic Basis Between Major Depression Disorder and Eight Types of Gastrointestinal Diseases.
    Genet Res (Camb). 2025;2025:6931243.
    PubMed    
    Abstract available
    
    

22. HSU LH, Chou YP, Shen TL, Wieczorek D, et al
    Otilonium bromide exhibits novel antifungal activity against Candida albicans via regulating iron homeostasis.
    Virulence. 2026;17:2609407.
    PubMed    
    Abstract available
    
    

23. TACK C, Van den Houte K, Besard L, Capiau L, et al
    A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial.
    BMC Gastroenterol. 2025 Dec 23. doi: 10.1186/s12876-025-04494.
    PubMed    
    Abstract available
    
    

24. DOWRICK JM, Roy NC, Carco C, James SC, et al
    Integrated multi-omic and symptom clustering reveals lower-gastrointestinal disorders of gut-brain interaction heterogeneity.
    Gut Microbes. 2026;18:2604871.
    PubMed    
    Abstract available
    
    

25. PORCHIA DD, Wang Y, Zhou Z, Chen M, et al
    Cannabis use, microbial diversity and Dialister abundance in older adults with HIV: A cross-sectional study.
    HIV Med. 2025 Dec 22. doi: 10.1111/hiv.70180.
    PubMed    
    Abstract available
    
    

26. PROSPERO L, Riezzo G, Laselva G, D'Attoma B, et al
    Somatization, psychological distress, and quality of life across fibromyalgia, irritable bowel syndrome, and their comorbid phenotype: a cross-sectional clinical comparison.
    Front Psychol. 2025;16:1709017.
    PubMed    
    Abstract available
    
    

27. ELKALLA MA, Ali YG, Ewais MM, Taha AS, et al
    Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review.
    Clin Rheumatol. 2025 Dec 22. doi: 10.1007/s10067-025-07861.
    PubMed    
    Abstract available
    
    

28. VON MUHLENBROCK C, Aronsohn F, Quera R, Madrid AM, et al
    The role of dietary fiber in the gastrointestinal tract: when, how and why?
    Best Pract Res Clin Gastroenterol. 2025;79:102080.
    PubMed    
    Abstract available
    
    

29. BIESIEKIERSKI JR
    Clinical utility of gluten restriction in gastrointestinal disorders: Evidence, practice, and reappraisal of non-coeliac gluten sensitivity.
    Best Pract Res Clin Gastroenterol. 2025;79:102086.
    PubMed    
    Abstract available
    
    

30. BERSCHBACK M, Abber S, Smith J, Staller K, et al
    Avoidant/restrictive food intake disorder in disorders of gut-brain interaction.
    Best Pract Res Clin Gastroenterol. 2025;79:102078.
    PubMed    
    Abstract available
    
    

31. VAN DEN HOUTE K
    Dietary approaches in functional bowel disorders.
    Best Pract Res Clin Gastroenterol. 2025;79:102077.
    PubMed    
    Abstract available
    
    

32. BUTT MF, Reghefaoui MH, Benedict AS, Reghefaoui M, et al
    Irritable Bowel Syndrome in Inflammatory Bowel Disease: An Evidence-Based Practical Review.
    J Clin Med. 2025;15:116.
    PubMed    
    Abstract available
    
    

33. CHOJNACKI C, Medrek-Socha M, Chojnacki J, Gasiorowska A, et al
    Multi-Strain Probiotic Improves Tryptophan Metabolism and Symptoms in Chronic Fatigue Syndrome Patients with Co-Occurring Irritable Bowel Syndrome: An Open-Label Pilot Study.
    Nutrients. 2026;18:174.
    PubMed    
    Abstract available
    
    

34. RUTA F, Avram C, Mardale E, Maior R, et al
    Histamine-Producing Intestinal Dysbiosis and Its Role in Lower Urinary Tract Infections and Irritable Bowel Syndrome in Young Women.
    Nutrients. 2025;18:16.
    PubMed    
    Abstract available
    
    

35. CADUNGOG MEGT, Tayo LL
    Microinflammation-Driven Gene Expression Dynamics in the Pathogenesis of Metabolic Disorders and Cancer.
    Biology (Basel). 2025;15:19.
    PubMed    
    Abstract available
    
    

36. PENG F, Xu K, Ba Q, Bi H, et al
    Investigating the causal roles of cholesterol and triglyceride subfractions across lipoproteins in irritable bowel syndrome: a Mendelian randomization study.
    Metabol Open. 2025;29:100434.
    PubMed    
    Abstract available
    
    

37. TAO QF, Hua C, Zhuo X, Mou JJ, et al
    Face-to-Face Versus Digital, Telephone-Delivered, and Self-Help Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Systematic Review and Bayesian Indirect Treatment Comparison Meta-Analysis.
    J Med Internet Res. 2026;28:e75833.
    PubMed    
    Abstract available
    
    

38. KERCKHOVE N, Zerbib F, Chambaz M, Mion F, et al
    Ethosuximide and Irritable Bowel Syndrome-Related Abdominal Pain: A Randomized Clinical Trial.
    JAMA Netw Open. 2026;9:e2551368.
    PubMed    
    Abstract available
    
    

39. BADWEI N, Abdelsalam A, Wassif GO, El-Din HES, et al
    Frequency and predictive role of intestinal parasitic infections with irritable bowel syndrome in Egyptian patients: a case-control study.
    Infection. 2026 Jan 8. doi: 10.1007/s15010-026-02724.
    PubMed    
    Abstract available
    
    

40. ERLITA D, Shatri H, Fauzi A, Abdullah M, et al
    The Role of Probiotics in Depression and Quality of Life in Patients with Irritable Bowel Syndrome.
    Acta Med Indones. 2025;57:485-492.
    PubMed    
    Abstract available
    
    

41. POSLUSNEY MS, Li Q, Buchler IP, Huang Y, et al
    Development of a Novel Benzodiazepine to Delineate Peripheral GABA-A Signaling Mechanisms in Visceral Pain Syndromes.
    Cell Mol Gastroenterol Hepatol. 2026 Jan 5:101704.
    PubMed    
    Abstract available
    
    

42. DA COSTA PM, Nunes PIG, Ciurleo GCV, Junior JWLT, et al
    The Role of Extracellular Vesicles as Diagnostic Tools in Gut-Brain Axis Disorders.
    Mol Neurobiol. 2026;63:349.
    PubMed    
    Abstract available
    
    

43. NAKANISHI T, Drueke TB, Kuragano T
    Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesis.
    Clin Kidney J. 2025;19:sfaf375.
    PubMed    
    Abstract available
    
    

44. LAMBIASE C, Rettura F, Sciume GD, Tedeschi R, et al
    Targeting gamma-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axis.
    Front Pharmacol. 2025;16:1677037.
    PubMed    
    Abstract available
    
    

45. ALHAJAJI R, Alfahmi M, Alshareef EM, Salim AMK, et al
    Does amitriptyline help for irritable bowel syndrome pain management?: An updated systematic review and meta-analysis.
    Medicine (Baltimore). 2026;105:e46869.
    PubMed    
    Abstract available
    
    

46. BRUNO A, Saccoccio V
    Improvement of Gastrointestinal Symptoms After Diastasis Recti Repair: A Prospective Study.
    Aesthetic Plast Surg. 2026 Jan 5. doi: 10.1007/s00266-025-05588.
    PubMed    
    Abstract available
    
    

47. GASPERI M, Gerstenberger A, Naliboff B, Afari N, et al
    Exploring Sex Differences in Irritable Bowel Syndrome Prevalence, Environmental Risk, and Comorbidities: A Population-Based Cohort Study of Veterans.
    Clin Transl Gastroenterol. 2026 Jan 5. doi: 10.14309/ctg.0000000000000967.
    PubMed    
    Abstract available
    
    

48. BALLENA-CAICEDO J, Valladolid-Sandoval LAM, Zuzunaga-Montoya FE, Vera-Ponce VJ, et al
    Global Prevalence of Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.
    Gastroenterology Res. 2025;18:308-321.
    PubMed    
    Abstract available
    
    

49. HU S, Xu Y, Chen J, Zhang L, et al
    Efficacy and safety of acupuncture for chemotherapy-induced diarrhea in colorectal cancer patients: a protocol for a systematic review and meta-analysis.
    Syst Rev. 2026 Jan 17. doi: 10.1186/s13643-026-03074.
    PubMed    
    Abstract available
    
    

50. SAINI U, Aggen SH, Oldehinkel AJ, Rosmalen JGM, et al
    Disentangling comorbidity: symptom dimensions of internalizing and functional disorders in a large general population sample.
    BMC Psychiatry. 2026 Jan 16. doi: 10.1186/s12888-026-07797.
    PubMed    
    
    
    

51. LI Y, Liu S, Zhang Q, Zhang S, et al
    Maternal Smoking, Lactation and Risk of Incident Irritable Bowel Syndrome in Offspring: A Large-scale Prospective Cohort Study.
    Am J Clin Nutr. 2026 Jan 14:101200. doi: 10.1016/j.ajcnut.2026.101200.
    PubMed    
    Abstract available
    
    

52. CHEUNG SLY, Kenway LC
    Pathophysiological Mechanisms and Nonpharmacological Interventions in Irritable Bowel Syndrome: Current Insights and Future Directions.
    J Nutr Metab. 2026;2026:4520019.
    PubMed    
    Abstract available
    
    

53. CHENG J, Zhang T, Cui X, Wu P, et al
    Identification and Quantification of Structurally Related Peptide Impurity in Linaclotide by Liquid Chromatography-High Resolution Mass Spectrometry.
    Rapid Commun Mass Spectrom. 2026;40:e70030.
    PubMed    
    Abstract available
    
    

54. MORAIS T, Couto G, Rocha R, Santana G, et al
    PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW.
    Arq Gastroenterol. 2026;62:e25081.
    PubMed    
    Abstract available
    
    

55. MAGGO J, Ng HM, Bayer SB, Wall CL, et al
    Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study.
    JMIR Res Protoc. 2026;15:e75286.
    PubMed    
    Abstract available
    
    

56. MILLER CB, Bader GA, Kay CL
    Fecal Microbiota Transplantation in 2025: Two Steps Forward, One Step Back.
    Curr Gastroenterol Rep. 2026;28:5.
    PubMed    
    Abstract available
    
    

57. LADEWSKI AM, Orleck KD, Skarbinski KF
    Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.
    J Am Assoc Nurse Pract. 2026 Jan 13. doi: 10.1097/JXX.0000000000001218.
    PubMed    
    Abstract available
    
    

58. MATHEW GT, Novak P
    Prevalence of Central Sensitization in Postural Tachycardia Syndrome.
    JAMA Netw Open. 2026;9:e2553694.
    PubMed    
    Abstract available
    
    

59. ALI S, Banda A, Ramirez-Matos C, Cohen P, et al
    From Years of Pain to a Name: Fibromyalgia Uncovered.
    Cureus. 2025;17:e98981.
    PubMed    
    Abstract available
    
    

60. LIU Y, Yan X, Yang J, Zhang D, et al
    Efficacy and safety of non-pharmacological therapies for irritable bowel syndrome with diarrhoea: protocol for systematic review and network meta-analysis.
    BMJ Open. 2026;16:e105579.
    PubMed    
    Abstract available
    
    

61. DIMIDI E, Whelan K, Scott SM
    Dietary guidelines for gastrointestinal disorders: key to optimizing practice but more work needed.
    Nat Rev Gastroenterol Hepatol. 2026 Jan 22. doi: 10.1038/s41575-025-01171.
    PubMed    
    
    
    

62. MIKO S, Kache PA, Imada E, Freeland AL, et al
    Postinfectious Syndromes and Long-Term Sequelae after Giardia Infections.
    Emerg Infect Dis. 2025;31:45-52.
    PubMed    
    Abstract available
    
    

63. CHATZOPOULOU MS, Vumma R, Prado S, Scharf MW, et al
    Development of a novel humanized gut-brain axis model as a tool toward personalized nutrition.
    Commun Biol. 2026;9:73.
    PubMed    
    Abstract available
    
    

64. FARSI DN, Whelan K, Dimidi E
    Perceptions of the Role of Diet Among People With Constipation: Dietary Contributors and Relievers to Symptoms and Research Priorities.
    J Hum Nutr Diet. 2026;39:e70201.
    PubMed    
    Abstract available
    
    

65. YEH ST, Li MY, Chen YC
    Mental and physical health outcomes among intimate partner violence survivors in Taiwan: A nationwide registry-based case control study.
    World J Psychiatry. 2026;16:112745.
    PubMed    
    Abstract available
    
    

66. SUGAYA N, Izawa S, Sasaki T
    Effects of irritable bowel syndrome and related cognitive-behavioral and occupational stress factors on the productivity and abdominal symptoms of Japanese workers: a longitudinal study.
    Biopsychosoc Med. 2026 Jan 19. doi: 10.1186/s13030-026-00349.
    PubMed    
    
    
    

67. LYU D, Wang X, Zhang J, Fu S, et al
    Glucocorticoid signaling mitigates colitis-associated visceral hypersensitivity by suppressing 5-HT release in enterochromaffin cells via a GR-PI3K-SGK1 axis.
    Int Immunopharmacol. 2026;172:116207.
    PubMed    
    Abstract available
    
    

68. KRUEGER A, Waheed U, Santucci N
    Overlap of Structural Gastrointestinal Disorders in Children With Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2026;38:e70231.
    PubMed    
    Abstract available
    
    

69. MULAK A
    The Hidden Role of Dreams and Nightmares in Gastrointestinal Disorders: Exploring a Nocturnal Blind Spot in Sleep Research.
    Neurogastroenterol Motil. 2026;38:e70240.
    PubMed    
    
    
    

70. ZHUANG Z, Lv B, Chen Y, Chen J, et al
    The effect of Massa Medicata Fermentata on the cytokine secretion of colonic mucosa and visceral sensitivity in rats with IBS-D.
    Front Cell Infect Microbiol. 2026;15:1616796.
    PubMed    
    Abstract available
    
    

71. HONG J, Ji R, Wang P, Huang F, et al
    A set of downregulated pleiotropic genes are possible multi-omics biomarkers underlying the irritable bowel syndrome-non-alcoholic fatty liver disease comorbidity.
    Am J Transl Res. 2025;17:9494-9515.
    PubMed    
    Abstract available
    
    

72. KUMAR A, Sarangi Y, Kaw P
    Gene, genetics and genetic medicines in gastroenterology: Current status and its future.
    World J Gastroenterol. 2026;32:112496.
    PubMed    
    Abstract available
    
    

73. BOGDANOWSKA-CHARKIEWICZ D, Malinowska U, Daniluk J
    An umbrella review of meta-analyses on the low-FODMAP diet in IBS.
    Front Nutr. 2026;12:1714281.
    PubMed    
    Abstract available
    
    

74. JIN R, Zhou Z, Lou Y, Wang X, et al
    Peoniflorin Alleviates Corticotropin-Releasing Factor-Induced Irritable Bowel Syndrome by Improving the Intestinal Barrier Function through the Inhibition of the CRFR1/ROCK2/MLC Signaling Pathway.
    J Agric Food Chem. 2026 Jan 19. doi: 10.1021/acs.jafc.5c10339.
    PubMed    
    Abstract available
    
    

75. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    Bombesin improves visceral hypersensitivity and colonic hyperpermeability via BB(1) receptor-dependent multi-pathway mechanisms in a rat model of irritable bowel syndrome.
    Eur J Pharmacol. 2026;1015:178566.
    PubMed    
    Abstract available
    
    

76. DAMIANOS JA, Wang XJ, Camilleri M
    Mechanisms and pathophysiology leading to development of small intestinal microbial dysbiosis.
    Lancet Gastroenterol Hepatol. 2026 Jan 14:S2468-1253(25)00295.
    PubMed    
    Abstract available
    
    

77. SILVA H, Zheng T, Porter J, Barrett J, et al
    The Associations of Sucrase-Isomaltase Hypomorphic Variants With Long-Term Outcomes and Dietary Intake in an Australian Irritable Bowel Syndrome Population Educated on the FODMAP Diet: A Cross-Sectional and Retrospective Study.
    United European Gastroenterol J. 2026;14:e70173.
    PubMed    
    Abstract available
    
    

78. PONTES-SILVA A
    Heterogeneity and patient stratification in fibromyalgia and irritable bowel syndrome treatment studies: systematic review discussion.
    Clin Rheumatol. 2026 Jan 17. doi: 10.1007/s10067-026-07953.
    PubMed    
    
    
    

79. ZHENG NS, Bar N, Kuo B, Staller K, et al
    Research Communication: Healthcare Utilisation Patterns in Patients With Irritable Bowel Syndrome Across an Integrated Healthcare System.
    Aliment Pharmacol Ther. 2026;63:294-298.
    PubMed    
    Abstract available
    
    

80. KHASAWNEH M, Goodoory VC, Ng CE, Ford AC, et al
    Stability of Classification Systems for Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Dec 25. doi: 10.1111/apt.70503.
    PubMed    
    Abstract available
    
    

81. ALSAKARNEH S, Al Ta'ani O, Mahmoud MY, Syn WK, et al
    Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers-Danlos Syndrome: A Propensity-Matched Analysis of 118,256 Individuals.
    Aliment Pharmacol Ther. 2025 Dec 23. doi: 10.1111/apt.70506.
    PubMed    
    Abstract available
    
    

82. ZHANG M, Wellens J, Zhao J, Ji H, et al
    Psychological Resilience and Mental Wellbeing Mitigate the Risk of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003833.
    PubMed    
    Abstract available
    
    

83. GUTIERREZ-TORRES DS, Li F, Liao LM, Daniel CR, et al
    The Time-Dependent Association Between Irritable Bowel Syndrome and All-Cause and Cause-Specific Mortality in the NIH-AARP Cohort Study.
    Am J Gastroenterol. 2025 Nov 21. doi: 10.14309/ajg.0000000000003861.
    PubMed    
    Abstract available
    
    

84. CENTOR RM, Aziz I
    Annals On Call - Mediterranean Diet in the Management of Irritable Bowel Syndrome.
    Ann Intern Med. 2026 Jan 6:e2505558OC. doi: 10.7326/ANNALS-25-05558.
    PubMed    
    
    
    

85. CHANG A, Shahrvini B, Oh J, Prajapati DP, et al
    Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09633.
    PubMed    
    Abstract available
    
    

86. ANWAR DFF, Salma ZN, Oktaviani SD, Adiyatma FN, et al
    Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes.
    Eur J Gastroenterol Hepatol. 2025 Dec 24. doi: 10.1097/MEG.0000000000003074.
    PubMed    
    Abstract available
    
    

87. DIAZ-MUNOZ C, Bozzarelli I, Lopera-Maya EA, Belbasis L, et al
    Genetic dissection of stool frequency implicates vitamin B1 metabolism and other actionable pathways in the modulation of gut motility.
    Gut. 2026 Jan 20:gutjnl-2025-337059. doi: 10.1136/gutjnl-2025-337059.
    PubMed    
    Abstract available
    
    

88. MACK A, Halmos EP, Mogilevski T, Anderson EJ, et al
    A Critical Review of Persistent Gastrointestinal and Extraintestinal Symptoms in Quiescent Inflammatory Bowel Disease: Time for Greater Precision and Clarity.
    J Gastroenterol Hepatol. 2026 Jan 18. doi: 10.1111/jgh.70223.
    PubMed    
    Abstract available
    
    

89. CRISTOFORI F, Calabrese FM, De Angelis M, Francavilla R, et al
    Data over doubt: Clarifications on calcium butyrate efficacy in pediatric irritable bowel syndrome.
    J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70326.
    PubMed    
    
    
    

90. VERMEIJDEN NK, Gordon M, Benninga M, Vlieger A, et al
    Analysis of "Calcium butyrate efficacy in pediatric irritable bowel syndrome".
    J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70328.
    PubMed    
    
    
    

91. YOUNGINER ST, Westbrook A, Buzenski J, Dykes C, et al
    Health-related quality of life in youth with chronic gastrointestinal disease following a biofeedback enhanced cognitive behavioral therapy intervention: A randomized controlled trial.
    J Pediatr Gastroenterol Nutr. 2026 Jan 4. doi: 10.1002/jpn3.70333.
    PubMed    
    Abstract available
    
    

92. PASRICHA PJ, Talley NJ
    Functional Dyspepsia.
    N Engl J Med. 2026;394:166-176.
    PubMed    
    Abstract available
    
    

93. GUO D, Song Y, Yuan L, Chu W, et al
    The gut-Joint axis: investigating functional gastrointestinal disorders as risk factors for prosthetic joint infections a retrospective case-control study.
    Postgrad Med. 2026 Jan 21:1-6. doi: 10.1080/00325481.2026.2619422.
    PubMed    
    Abstract available
    
    

94. HAMBERG LEVEDAHL K, Carlson M, Nilsson GP, Jakobsson Larsson B, et al
    Investigating instruments for evaluation of gastrointestinal burdens in patients with systemic mastocytosis: an exploratory multimethod study.
    Scand J Gastroenterol. 2025 Dec 21:1-10. doi: 10.1080/00365521.2025.2604778.
    PubMed    
    Abstract available
    
    

95. DEMIR E, Tunc A, Baser B, Mermer S, et al
    Genetic sucrase-isomaltase deficiency: epidemiology, clinical spectrum, and diagnostic challenge.
    Scand J Gastroenterol. 2026 Jan 12:1-9. doi: 10.1080/00365521.2026.2615396.
    PubMed    
    Abstract available
    
    

96. ROHNER S, Schnepper R, Meienberg A, Bopp K, et al
    Protocol of the digital long COVID study: A single-center, registry-based, feasibility and clinical evaluation study to investigate a 12-week digital intervention program for people affected by post-COVID-19 condition.
    PLoS One. 2026;21:e0340385.
    PubMed    
    Abstract available